Liver Health

Non-alcoholic fatty liver disease (NAFLD) — now increasingly
referred to as metabolic-associated steatotic liver disease
(MASLD) — is the most common liver condition worldwide,
affecting an estimated 25% of the global population.
 
NAFLD develops when excess fat accumulates in liver cells in
the absence of significant alcohol consumption. It is strongly
linked to insulin resistance, visceral obesity, and metabolic
syndrome, and can progress silently from simple steatosis to
non-alcoholic steatohepatitis (NASH), fibrosis, and cirrhosis.
 
This section covers the mechanisms behind hepatic fat
accumulation, how NAFLD is diagnosed and staged, its
relationship to broader metabolic dysfunction, and the
dietary and lifestyle interventions with the strongest
clinical evidence.